dihydroartemisinin

Dihydroartemisinin (Artenimol) is an antimalarial drug.

α-Dihydroartemisinin (α-Dihydroqinghaosu) is an intermediate of artemisinin-based antimalarial compounds with good antimalarial and anticancer activity, and can be used in the study of lupus erythematosus.

Artemether (CGP 56696) is an antimalarial agent used to treat acute uncomplicated malaria.

Dihydroartemisinin (mixture of α and β isomers) is a useful organic compound for research related to life sciences. The catalog number is T64399 and the CAS number is 131175-87-6.

Dihydroartemisinin diketo aldehyde is an impurity of Artemether.

Anhydro Dihydro Artemisinin is a natural product from Artemisia carvifolia Buch.-Ham. ex Roxb.

Tetradecanoylcarnitine (L-Myristoylcarnitine) is an acylcarnitine involved in the beta-oxidation of long-chain fatty acids, and is a potential marker for very-long-chain coenzyme A dehydrogenase deficiency. alpha-Dihydroartemisinin is a potent and selective inhibitor with multiple targets.

Piperaquine tetraphosphate, a potent antimalarial agent, demonstrates inhibitory effects against both chloroquine-sensitive and chloroquine-resistant malaria isolates. When combined with dihydroartemisinin, it holds potential for researching chloroquine-resistant malaria [1] [2].